- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06056401
Comparison of Volume-controlled and Pressure-controlled Ventilation in Clasp-knife Position
September 20, 2023 updated by: Cai Xinyuan, Sun Yat-sen University
Comparison of Volume-controlled and Pressure-controlled Ventilation in Clasp-knife Position for Robot-assisted Laparoscopic Urological Surgery
Carbon dioxide (CO2) pneumoperitoneum and clasp-knife positioning are commonly used to improve surgical access during robot-assisted laparoscopic urological surgery.
However, these methods are sometimes associated with several unwanted cardiopulmonary effects such as increased mean arterial pressure, decreased pulmonary compliance and functional residual capacity, increased peak inspiratory pressure, and respiratory acidosis in association with hypercarbia.
Volume-controlled ventilation (VCV) is the most commonly used method of ventilation during general anesthesia.
It provides fixed minute ventilation and pulmonary resistance, which affect airway pressure.
In pressure-controlled ventilation (PCV), constant inspiratory airway pressure can be achieved by decelerating the flow.
However, minute ventilation is not fixed .
CO2 pneumoperitoneum in the clasp-knife positioning can influence hemodynamic variables, including blood pressure, heart rate, and cardiac output.
This is because changes in airway pressure affect intrathoracic pressure and the function of the heart itself.
In this randomized study, we investigated the effects of VCV and PCV on peak inspiratory pressure during robot-assisted laparoscopic urological surgery involving CO2 pneumoperitoneum in the clasp-knife position.
Study Overview
Status
Completed
Detailed Description
After careful screening, 60 patients were enrolled in the trial.
The investigators monitored patients' breathing, circulation and carbon metabolism by measuring arterial gas, cardiac output monitoring, respiratory parameters and circulation parameters at different times in both groups of patients.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510060
- Cai Xinyuan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients undergoing urological surgery in clasp-knife position
- between the age of 18 and 65
- America Society of Anesthesiologist Grades I-II.
Exclusion Criteria:
- Morbid obesity
- systolic blood pressure < 90 mmHg)
- heart rate < 60 beats per minute or > 100 beats per minute
- peripheral blood oxygen saturation < 90%
- Complicated with severe liver and kidney injury.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: VCV group
For patients assigned in this group, after standard anesthesia, in which the following drugs were used (midazolam 0.05 mg / kg;propofol 1.5-2.5 mg / kg; sufentanil 0.3-0.5 μg / kg; and cisatracurium0.2-0.3 mg / kg), their mechanical ventilation mode was adjusted to the VCV mode.
|
Hemodynamic variables, respiratory variables and arterial blood gas were measured and recorded 15 minutes after induction of anesthesia (T1), 15 minutes after establishment of a folding knife position (T2), 30 and 60 minutes after CO2 pneumoconiosis (T3 and T4), and 15 minutes after pneumoconiosis (T5).
Hemodynamic variables measured included mean arterial pressure , heart rate , cardiac output, cardiac index, stroke volume index and stroke volume variation.
Breathing variables include tidal volume, minute ventilation , respiratory rate , airway frontal pressure , mean airway pressure , plateaus airway pressure , peripheral oxygen saturation , oxygen saturation , and oxygen response .
Arterial blood gas variables include pH value, arterial carbon dioxide, arterial oxygen pressure , alkali surplus , alveolar oxygen pressure , and bicarbonate of soda ion concentration .
|
Experimental: PCV group
For patients assigned in this group, after standard anesthesia, in which the following drugs were used (midazolam 0.05 mg / kg;propofol 1.5-2.5 mg / kg; sufentanil 0.3-0.5 μg / kg; and cisatracurium0.2-0.3 mg / kg), their mechanical ventilation mode was adjusted to the PCV mode.
|
Hemodynamic variables, respiratory variables and arterial blood gas were measured and recorded 15 minutes after induction of anesthesia (T1), 15 minutes after establishment of a folding knife position (T2), 30 and 60 minutes after CO2 pneumoconiosis (T3 and T4), and 15 minutes after pneumoconiosis (T5).
Hemodynamic variables measured included mean arterial pressure , heart rate , cardiac output, cardiac index, stroke volume index and stroke volume variation.
Breathing variables include tidal volume, minute ventilation , respiratory rate , airway frontal pressure , mean airway pressure , plateaus airway pressure , peripheral oxygen saturation , oxygen saturation , and oxygen response .
Arterial blood gas variables include pH value, arterial carbon dioxide, arterial oxygen pressure , alkali surplus , alveolar oxygen pressure , and bicarbonate of soda ion concentration .
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Check the patient's ventilation effect at a specific time
Time Frame: T1(15 minutes after induction of anesthesia)
|
we recorded the patients' peak inspiratory pressure
|
T1(15 minutes after induction of anesthesia)
|
Check the patient's ventilation effect at a specific time
Time Frame: T2(15 minutes after position was changed)
|
we recorded the patients' peak inspiratory pressure
|
T2(15 minutes after position was changed)
|
Check the patient's ventilation effect at a specific time
Time Frame: T3(30 minutes after pneumoperitoneum was established)
|
we recorded the patients' peak inspiratory pressure
|
T3(30 minutes after pneumoperitoneum was established)
|
Check the patient's ventilation effect at a specific time
Time Frame: T4(60 minutes after pneumoperitoneum was established)
|
we recorded the patients' peak inspiratory pressure
|
T4(60 minutes after pneumoperitoneum was established)
|
Check the patient's ventilation effect at a specific time
Time Frame: T5(15 minutes after pneumoperitoneum was released)
|
we recorded the patients' peak inspiratory pressure
|
T5(15 minutes after pneumoperitoneum was released)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Wenqian Lin, anesthesiology department of Sun Yat-sen University Cancer Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 15, 2022
Primary Completion (Actual)
February 24, 2023
Study Completion (Actual)
February 24, 2023
Study Registration Dates
First Submitted
March 8, 2023
First Submitted That Met QC Criteria
September 20, 2023
First Posted (Actual)
September 28, 2023
Study Record Updates
Last Update Posted (Actual)
September 28, 2023
Last Update Submitted That Met QC Criteria
September 20, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 2022-FXY-282
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Robotic Surgery
-
Otto-von-Guericke University MagdeburgRecruiting
-
McMaster UniversityNot yet recruitingRobotic Surgery | Bariatric Surgery
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedRobotic Surgery | Kidney DonationNetherlands
-
Chinese University of Hong KongRecruiting
-
The Cooper Health SystemRecruiting
-
University of Illinois at ChicagoCompletedPediatric Robotic SurgeryUnited States
-
Borja Alcobía-Díaz MD, PhDRecruitingClinical and Radiological Results in Robotic Assisted Knee Prosthetic Surgery With ROSA® Knee SystemKnee Prosthetic Surgery | Robotic AssistanceSpain
-
Nitin Sethi, DNBCompleted
-
Lawson Health Research InstituteCompletedRobotic Surgery Simulation TrainingCanada
-
Seoul National University HospitalEnrolling by invitation